The company sources raw materials, isotopes, and clinical trial materials for nonclinical and potential future clinical and commercial needs. It faces challenges in identifying and retaining suitable vendors, including contract research organizations (CROs) and clinical manufacturing organizations, due to the limited number of suppliers qualified to handle radioactive material. Sole-source vendor relationships present risks such as delays in obtaining diagnostic radiotracers, which have postponed the start of the Phase 1 clinical trial for IM-3050. Additionally, the short half-life of Lu-177 creates distribution challenges and increases expenses. The company is in the early stages of developing internal sales and marketing capabilities for commercialization and may rely on third parties for marketing and distribution; however, there is no assurance that such arrangements will be established on acceptable terms or at all.
Immunome Inc's Comment on Supply Chain
The company sources raw materials, isotopes, and clinical trial materials for nonclinical and potential future clinical and commercial needs. It faces challenges in identifying and retaining suitable vendors, including contract research organizations (CROs) and clinical manufacturing organizations, due to the limited number of suppliers qualified to handle radioactive material. Sole-source vendor relationships present risks such as delays in obtaining diagnostic radiotracers, which have postponed the start of the Phase 1 clinical trial for IM-3050. Additionally, the short half-life of Lu-177 creates distribution challenges and increases expenses. The company is in the early stages of developing internal sales and marketing capabilities for commercialization and may rely on third parties for marketing and distribution; however, there is no assurance that such arrangements will be established on acceptable terms or at all.
Sources:
Immunome Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Immunome Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
